Concomitant oncopathological changes in the prostate of urinary bladder cancer patients undergoing radical cystoprostateectomy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim To determine the incidence of spreading bladder transitional cell carcinoma and primary adenocarcinoma to the prostate in patients with bladder cancer undergoing radical cystectomy. Materials and methods From 1995 to 2016, 283 men underwent radical cystectomy with removal of the bladder, perivesical tissue, prostate, seminal vesicles and pelvic lymph nodes. Prostate sparing cystectomy was performed in 45 (13.7%) patients. The whole prostate and the apex of the prostate were preserved in 21 (6.4%) and 24 (7.3%) patients, respectively. Results and discussion The spread of transitional cell cancer of the bladder to the prostate occurred in 50 (15.2%) patients. Twelve (3.6%) patients were found to have primary prostate adenocarcinoma. Clinically significant prostate cancer was diagnosed in 4 (33.3%) patients. Conclusion We believe that the high oncological risk of prostate sparing cystectomy, despite some functional advantages, dictates the need for complete removal of the prostate in the surgical treatment of bladder cancer.

Full Text

Restricted Access

About the authors

B. K Komyakov

1.1. Mechnikov North-Western State Medical University of Minzdrav of Russia

Email: komyakovbk@mail.ru
Dr.Med.Sci., Prof., Head of Department of Urology

A. V Sergeev

I.I. Mechnikov NWSMU of Minzdrav of Russia

Email: urolsergeev@gmail.com
Dr.Med.Sci., Prof. at the Department of Urology

V. A Fadeev

I.I. Mechnikov NWSMU of Minzdrav of Russia

Email: fad_ur_75@mail.ru
Dr.Med.Sci., Prof. at the Department of Urology

K. I Ismailov

I.I. Mechnikov NWSMU of Minzdrav of Russia

Email: kit@awx.su
Ph.D. Student at the Department of Urology

A. Yu Ul’yanov

I.I. Mechnikov NWSMU of Minzdrav of Russia

Email: Doctor-drun.0704@yandex.ru
Ph.D. Student at the Department of Urology

A. Yu Shmelev

I.I. Mechnikov NWSMU of Minzdrav of Russia

Email: aludm2@mail.ru
Ph.D. Student at the Department of Urology

M. V Onoshko

1.1. Mechnikov NWSMU of Minzdrav of Russia

Email: onoshkospb@gmail.com
Associate Professor at the Department of Surgical Diseases of the Faculty of Dentistry with a Course of Coloproctology

References

  1. Комяков Б.К., Сергеев А.В., Фадеев В.А. Лимфодиссекция при радикальной цистэктомии. Вопросы онкологии. 2010;56(5):508-513
  2. Комяков Б.К., Фадеев В.А., Сергеев А.В. Цистэктомия и замещение мочевого пузыря у женщин. Журнал акушерства и женских болезней. 2011;LX(2):48-50
  3. Комяков Б.К., Гулиев Б.Г., Сергеев А.В. и соавт. Выживаемость больных раком мочевого пузыря после радикальной цистэктомии. Онкоурология. 2016;1(12):40-46
  4. Красный С.А., Суконко О.Г., Ролевич А.И. Результаты лечения больных раком мочевого пузыря с метастазами в регионарных лимфоузлах. Онкоурология. 2007;3:35-41
  5. Красный С.А., Суконко О.Г., Поляков С.Л. и соавт. Предикторы ранних тяжелых осложнений радикальной цистэктомии. Онкоурология. 2010;4:42-47
  6. Hautmann R.E., de Petriconi R.C., Volkmer B.G. Lessons learned from 1 000 neobladders; the 90-day complications rate. J Urol. 2010;184: 990-994.
  7. Hautmann R.E., de Petriconi R.C., Volkmer B.G. 25 years of experience with 1000 neobladders; long-term complications. J Urol. 2011;185:2207-2212.
  8. Kessler T.M., Burkhard F.C., Perimenis P. et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol. 2004;172:1323-1327.
  9. Shoenberg M.P., Walsch P.C., Breazeale D.R. et al. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year follow up. J Urol. 1996. Vol. 155. P. 490-494.
  10. Abol-Enein H., Tilki D., Mosbah A. et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single - center study. Eur.Urol. 2011; 60:572-577.
  11. Roth B., Burkhard F.C. The Role of lymphadenectomy in radical cystectomy. Eur. Urol. 2010;9:19-24.
  12. Brausi M., Gavioli M., Viola M. Radical cystectomy and orthotopic neobladder with prostate and seminal sparing in young patients with transitional cell carcinoma (TCC) of the bladder. Eur. Urol. 2005;4(Suppl.):61-66.
  13. Damiano R., Di Lorenzo G., Cantiello F. et al. Clinicopathological features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence - based analysis. Eur. Urol. 2007;52:648-657.
  14. Ong C.H., Schmitt M., Thalmann G.N., Studer U.E. Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results. J Urol. 2010;183:1337-1342.
  15. Revelo M.P., Cookson M.S., Chang S.S. et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2004;171:646-651.
  16. Rozet F., Lesur G., Cathelineau X. et al. Oncological evaluation of prostate sparing cystectomy: the montsouris long-term results. J Urol. 2008;179:2170-2175.
  17. Saad M., Abdel-Rahim M., Abol-Enein H., Ghoneim M.A. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review. BJUI. 2008;102:1544-1550.
  18. Winkler M.H., Livni N., Mannion E.M., Houdra D., Christmas T. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJUI. 2007;99:554-558.
  19. Pettus J.A., Al-Ahmadie H., Barocas D.A. et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
  20. Shen S.S., Lerner S.P., Muezzinoglu B., Truong L.D., Amiel G., Wheeler T.M. Prostatic involvement by transitional cell carcinoma in patient with bladder cancer and its prognostic significance. Hum. Pathol. 2006;37:726-734.
  21. Stamey T.A., Freiha F.S., McNeal J.E. et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer. 1993;71(Suppl. 3):933-938.
  22. Epstein J.I., Chan D.W., Sokoll L.J. et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol. 1998;160:2407-2411.
  23. Ruffion A., Manel A., Massoud W. et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology. 2005;65:703-707.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies